SecBot SecBot
Insider Cluster (3 insiders) ·Filed Aug 3, 2026

NRIX

Nurix Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 3 insiders, $0.5M total
Actionable Insight • Neutral

The insider cluster is too small to be informative, monitor for larger directional trades or a change in pattern. Focus on upcoming earnings or pipeline catalysts for real signals.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$24.69
T+0 close · Aug 3, 2026 · via day close
Latest settled
+5.14%
T+5 · $25.96
Vs SPY
+5.24%
α at T+5
Next horizon
T+20
due 3mo ago
  1. T+0 · Aug 4 $24.69entry
  2. T+1 · 3mo ago +1.74%α +1.94% · $25.12
  3. T+5 · 3mo ago +5.14%α +5.24% · $25.96
  4. T+20 · due 3mo ago Pending
  5. T+60 · due 20d ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three C-suite insiders at Nurix Therapeutics (NRIX) sold a combined $539K of stock in a 7-day window, representing only ~0.02% of the $2.4B market cap. The sales coincide with option exercises and appear to be routine liquidity/tax-related transactions, not a negative signal on the company's prospects.

Key Financial Metrics

Direction
selling
Total Value
$539.0K
Insiders
3

Key Facts

  • Total open-market sales: $539K (0.02% of $2.4B market cap)
  • Insiders: CFO van Houte, CSO Hansen, CLO Ring, all C-suite
  • Sales follow option exercises at $0 or $8.72 strike, consistent with tax withholding / diversification
  • No insider buying in the cluster, all activity is sell-side

Financial Impact

Trivial, $539K in sales vs $2.4B market cap is immaterial

dilutioninsider ownership

Risk Factors

  • Routine insider selling does not predict stock movement; no bearish signal here
  • Option exercises could lead to future dilution if insiders hold the shares, but sales are minimal

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NRIX-1785794472087

Track record

33 reports on NRIX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +53.71% at T+20 after the Jun 8, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.17 Now $14.73 −2.90% settles Dec 15
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.41 Now $14.73 −4.41% settles Dec 15
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  6. Nov 4, 202612d ago 144 Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  7. Nov 3, 202613d ago 144 Neutral 2/10 Entry $15.95 Now $14.73 −7.65% settles Dec 3
  8. Nov 3, 202613d ago 8-K Bearish 5/10 Entry $15.95 Now $14.73 +7.65% settles Dec 3
  9. Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $25.82 Now $14.73 −42.95% settles Dec 2
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $25.82 Now $14.73 −42.95% settles Dec 2
Showing 10 of 33

US Market Status

Market Closed · Opens Wed (11h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 3, 2026